Skip to content
Screener

Harrow HROW Accrued Expenses

Accrued Expenses at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$7.75M+2.7%
Bausch + Lomb logo
Bausch + LombBLCO
$1.42B+4.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$36.49M+17.4%
Opko Health logo
Opko HealthOPK
$77.76M-14.1%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$3.04B-9.5%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$11.89M+2.4%

Other financials

Income statement

See full
Revenue$70.7M+10.9%
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M
CapEx$491.0K+196%
Free cash flow-$10.2M

Valuation

See full
Market cap$1.52B+22.5%
Enterprise value$1.74B+6.3%
P/S5.5×+0.1×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemJune 30,2026December 31,2025
Current liabilities
Accounts payable and accrued expenses$34,062,000$41,959,000
Accrued rebates and copay assistance55,481,00042,236,000
Accrued payroll and related liabilities11,578,00010,432,000
Deferred revenue and customer deposits106,000788,000
Current portion of operating lease obligations944,000887,000
Total current liabilities102,171,00096,302,000
Operating lease obligations, net of current portion7,421,0007,905,000

Item 1. Financial Statements

FAQ

What is Harrow's accrued expenses?
Harrow (HROW) reported accrued expenses of $11.58M in Q2 2026.
How has Harrow's accrued expenses changed year-over-year?
Harrow's accrued expenses increased by 69.7% year-over-year, from $6.82M to $11.58M.
What is the long-term trend for Harrow's accrued expenses?
Over 5 years (2020 to 2025), Harrow's accrued expenses has grown at a 192.2% compound annual growth rate (CAGR), from $49K to $10.43M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Harrow's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude